You have 9 free searches left this month | for more free features.

ct-011

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma Trial in Boston, Haifa (CT-011, Dendritic Cell Fusion Vaccine)

Active, not recruiting
  • Multiple Myeloma
  • CT-011
  • Dendritic Cell Fusion Vaccine
  • Boston, Massachusetts
  • +2 more
Sep 5, 2022

Pancreatic Tumors, Cancer of the Pancreas, Tumors Pancreatic Trial in Augusta (CT-011, Gemcitabine)

Terminated
  • Pancreatic Neoplasms
  • +4 more
  • Augusta, Georgia
    Georgia Regents University
Jun 18, 2019

Breast Cancer, Colon Cancer, Pancreatic Cancer Trial run by the NCI (p53: 264-272 peptide, CT-011)

Withdrawn
  • Breast Cancer
  • +4 more
  • p53: 264-272 peptide
  • CT-011
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017

Renal Cell Carcinoma Trial in Boston (CT-011, DC/RCC fusion vaccine)

Terminated
  • Renal Cell Carcinoma
  • CT-011
  • DC/RCC fusion vaccine
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Dec 15, 2016

Lymphoma Trial in Houston (CT-011, Rituximab)

Completed
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 27, 2016

Melanoma, Malignant Melanoma Trial in Israel, United States (CT-011)

Completed
  • Melanoma
  • Malignant Melanoma
  • CT-011
  • New Haven, Connecticut
  • +17 more
Dec 16, 2015

Metastatic Colorectal Cancer Trial in Worldwide (CT-011, FOLFOX)

Completed
  • Metastatic Colorectal Cancer
  • Huntsville, Alabama
  • +30 more
Jun 10, 2015

Lymphoma, Large Cell, Diffuse, Lymphoma, Mixed Cell, Diffuse, Primary Mediastinal Large B-Cell Lymphoma Trial in India, Israel,

Completed
  • Lymphoma, Large Cell, Diffuse
  • +2 more
  • CT-011
  • La Jolla,, California
  • +26 more
Sep 8, 2014